Kyle A. Edgar
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
-
- PI3K/AKT/mTOR signaling in cancer
- Protein Degradation and Inhibitors
- Insect Resistance and Genetics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 14
- Insect Resistance and Genetics 2
- Genetics 6
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Jeffrey J. Wallin (9 shared papers)Marcia Belvin (10 shared papers)Deepak Sampath (10 shared papers)Lori S. Friedman (11 shared papers)Wei Wei Prior (3 shared papers)Leslie B. Lee (2 shared papers)Fernando G. Noriega (3 shared papers)Laurent Salphati (4 shared papers)
- Journals
- Cancer Research (7 papers)Genes & Cancer (2 papers)Journal of Insect Physiology (2 papers)Insect Molecular Biology (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesItalySingapore
In The Last Decade
Kyle A. Edgar
20 papers receiving 447 citations
Peers
Comparison fields: 5 of 68
- Genetics 90
- Molecular Biology 312
- Oncology 113
- Pathology and Forensic Medicine 48
- Pulmonary and Respiratory Medicine 76
Countries citing papers authored by Kyle A. Edgar
This map shows the geographic impact of Kyle A. Edgar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle A. Edgar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle A. Edgar more than expected).
Fields of papers citing papers by Kyle A. Edgar
This network shows the impact of papers produced by Kyle A. Edgar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle A. Edgar. The network helps show where Kyle A. Edgar may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle A. Edgar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 95 | |
| 2 | 2016 | 77 | |
| 3 | 2010 | 63 | |
| 4 | 2010 | 47 | |
| 5 | 2012 | 39 | |
| 6 | 2002 | 37 | |
| 7 | 2018 | 20 | |
| 8 | 2016 | 15 | |
| 9 | 2000 | 14 | |
| 10 | 2014 | 14 | |
| 11 | 2017 | 12 | |
| 12 | 1992 | 11 | |
| 13 | 2001 | 8 | |
| 14 | 2016 | 4 | |
| 15 | 2016 | 3 | |
| 16 | 2017 | 3 | |
| 17 | 2020 | 2 | |
| 18 | 2019 | 2 | |
| 19 | 2008 | 2 | |
| 20 | Abstract #3392: Transient pAkt increase after chemo exposure predicts strength of synergy for combinations of the PI3K inhibitor GDC-0941 and chemotherapeutics | 2009 | 1 |
About Kyle A. Edgar
Kyle A. Edgar is a scholar working on Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 20 papers that have together received 469 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (14 papers), Chronic Lymphocytic Leukemia Research (5 papers), Mosquito-borne diseases and control (3 papers), Lung Cancer Treatments and Mutations (3 papers), Neurobiology and Insect Physiology Research (2 papers), Insect Resistance and Genetics (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Genetics (90 citations), Molecular Biology (312 citations), Oncology (113 citations), Pathology and Forensic Medicine (48 citations) and Pulmonary and Respiratory Medicine (76 citations). Kyle A. Edgar has collaborated with scholars based in United States, Italy and Singapore. Frequent co-authors include Jeffrey J. Wallin, Marcia Belvin, Deepak Sampath, Lori S. Friedman, Wei Wei Prior, Leslie B. Lee, Fernando G. Noriega, Laurent Salphati, M A Wells and Megan Berry. Their work appears in journals such as Cancer Research, Genes & Cancer, Journal of Insect Physiology, Insect Molecular Biology and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.